OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Brown on Germline and Somatic Testing in Ovarian Cancer

April 2nd 2020

Jubilee Brown, MD, discusses germline and somatic testing in ovarian cancer.

Dr. Bakouny on the Utility of Checkpoint Inhibitors in Sarcomatoid RCC

April 2nd 2020

Ziad Bakouny, MD, MSc, discusses the utility of checkpoint inhibitors in renal cell carcinoma with sarcomatoid differentiation.

Dr. Kaseb on Research With Targeted Therapy in HCC

April 2nd 2020

Ahmed O. Kaseb, MD, a professor in the Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, discusses research with targeted therapy in hepatocellular carcinoma (HCC).

Dr. Bertino on the Impact of COVID-19 on Patients With Lung Cancer

April 2nd 2020

Erin M. Bertino, MD, a medical oncologist at The Ohio State University Comprehensive Cancer Center–James, discusses the potential impact of the novel coronavirus 2019 (COVID-19) on patients with lung cancer.

Dr. Raghav on Ongoing Research With Immunotherapy and Targeted Therapy in CRC

April 2nd 2020

Kanwal Raghav, MBBS, MD, associate professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses ongoing research with immunotherapy and targeted therapy in colorectal cancer (CRC).

Dr. Altomare on Treatment Options in ITP

April 1st 2020

Ivy P. Altomare, MD, discusses treatment options for patients with immune thrombocytopenia purpura.

Dr. Boorjian on Research With Nadofaragene Firadenovec in Nonmuscle Invasive Bladder Cancer

April 1st 2020

Stephen A. Boorjian, MD, professor of urology, Mayo Clinic, discusses research with intravesical nadofaragene firadenovec in patients with nonmuscle invasive bladder cancer (NMIBC).

Dr. Rosenberg on Enfortumab Vedotin/Pembrolizumab in Urothelial Carcinoma

April 1st 2020

Jonathan E. Rosenberg, MD, medical oncologist, chief, Genitourinary Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the updated results of the phase Ib/II EV-103 trial (NCT03288545) with enfortumab vedotin-ejfv (Padcev) and pembrolizumab (Keytruda) in patients with locally advanced or metastatic urothelial carcinoma.

Dr. Carbone Provides Perspective on COVID-19

April 1st 2020

David P. Carbone, MD, PhD, director of the Thoracic Oncology Center at The Ohio State University Comprehensive Cancer Center–James, provides perspective on the novel coronavirus 2019 (COVID-19).

Dr. Dawar on Challenges With Neratinib in Metastatic HER2+ Breast Cancer

April 1st 2020

Richa Dawar, MD, discusses challenges with the use of neratinib in patients with metastatic HER2-positive breast cancer.

Dr. Singal on Systemic Therapies in HCC

April 1st 2020

Amit G. Singal, MD, discusses systemic therapies in hepatocellular carcinoma.

Dr. Jochelson on the Limitations of Mammography and Ultrasound in Screening for Breast Cancer

April 1st 2020

Maxine S. Jochelson, MD, discusses the limitations of mammography and ultrasound in screening patients for breast cancer.

Dr. Socinski on Recommendations for Molecular Testing in Lung Cancer

March 31st 2020

Mark A. Socinski, MD, discusses his recommendations for conducting molecular testing in lung cancer.

Dr. Kelly on Challenges With Starting Immunotherapy in Lung Cancer

March 31st 2020

Karen Kelly, MD, discusses challenges with choosing when to start immunotherapy in patients with lung cancer.

Dr. Foss on the Unmet Need in Cutaneous T-cell Lymphoma

March 31st 2020

Francine Foss, MD, discusses the challenges faced in cutaneous T-cell lymphoma.

Dr. Levine on Programmed Anticancer Immunity With T-cell and NK-cell Therapies

March 31st 2020

Bruce L. Levine, PhD, discusses engineered anticancer immunity with T-cell and natural killer–cell therapies.

Dr. Curran on the Integration of Immunotherapy With Radiation Therapy in Lung Cancer

March 31st 2020

Walter J. Curran, Jr, MD, FACR, FASCO, explains the eligibility criteria for immunotherapy and radiation in patients with lung cancer.

Dr. Donington on Neoadjuvant Immunotherapy in Lung Cancer

March 31st 2020

Jessica Donington, MD, MSCR, discusses the effectiveness of neoadjuvant immunotherapy and how it compares with neoadjuvant chemotherapy in patients with lung cancer.

Dr. Burtness on the Effectiveness of Immunotherapy in Head and Neck Cancers

March 31st 2020

Barbara Burtness, MD, discusses the effectiveness of immunotherapy in patients with platinum-refractory head and neck cancers.

Dr. Pavlick on Sequencing Challenges in BRAF-Mutant Melanoma Treatment

March 31st 2020

Anna C. Pavlick, DO, discusses sequencing challenges faced in the treatment of patients with BRAF-mutant melanoma.